Gapping up
In reaction to strong earnings/guidance: CETV +19.9% (also announces refinancing of 2016 notes with proceeds from a rights offering and financing provided by Time Warner), OVTI +15.4%, IG +13.1%, YOKU +11.1%, WUBA +10.7%, MELI +10.4%, NMBL +9% (also assumed with a Buy at Needham; tgt $62; strong F4Q & F1Q outlook), REGI +7.2%, SLXP +4.7%, EVC +3.8% (light volume), EPZM +3.7%, AT +3.6%, AL +3.5%, (light volume), TUMI +3% (light volume), JOE +3% (light volume), GLOG +2.9%, BCEI +2.9% (ticking higher), PMC +2.8% (light volume), FNHC +2.7% (thinly traded), MNST +2.6%, QUNR +2.4%, CLVS +2.1%, AUXL +2.1%, DDD +1.8%, SFM +0.8%, CRM +0.6% .
M&A related: SOHU +7.3% (Sohu and Tencent video segment merger speculation), JOSB +3.6% and MW +2.9% (Jos. A. Bank rejects $63.50 per share tender offer; agrees to meet with the Men's Warehouse - willing to consider a higher price), ARIA +1.1% (continued strength following late push higher on M&A speculation).
Other news: MEIP +24% (Treatment of acute myeloid leulemia received orphan designation), CLSN +8.1% (announces positive interim data from Phase 2 DIGNITY trial in breast cancer), CARA +6% (continued strength), NVAX +5.3% (Announces Extension of Contract for Advanced Development of Recombinant Influenza Products and Pandemic Preparedness With HHS-BARDA), QIWI+4.8% (may be attributed to Ukraine plans to limit FX cash withdrawals to UAH15K per day), PRKR +4.3% (. announces Qualcomm (QCOM) dismisses counterclaims against ParkerVision), GLUU +4% (may be attributed to MAT buying MEGA Brands), ZU +2.2% (continued momentum), ESI +2.1% ( S.A.C. Capital discloses 5.0% passive stake in 13G filing), ALU +1.9% (still checking for anything specific), ACT +1.7% (ticking higher; confirms that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Dronedarone Hydrochloride Tablets 400 mg), WDAY +1.2% (following positive MadMoney mention),WHR +0.7% (ticking higher following positive MadMoney mention), PEP +0.4% (Director Cook in letter to activist Nelson Peltz: Board and mgmt are comfortable and in complete alignment in rejecting your proposal), HOT +0.1% (following positive MadMoney mention).
Analyst comments: MITT +1.4% (upgraded to Buy at Wunderlich; tgt raised to $19), CS +1.1% (upgraded to Overweight from Equal Weight at Barclays), TOT +0.7% (upgraded to Buy from Neutral at UBS), TRIP +0.6% (upgraded to Neutral from Negative at Susquehanna)
M&A related: SOHU +7.3% (Sohu and Tencent video segment merger speculation), JOSB +3.6% and MW +2.9% (Jos. A. Bank rejects $63.50 per share tender offer; agrees to meet with the Men's Warehouse - willing to consider a higher price), ARIA +1.1% (continued strength following late push higher on M&A speculation).
Other news: MEIP +24% (Treatment of acute myeloid leulemia received orphan designation), CLSN +8.1% (announces positive interim data from Phase 2 DIGNITY trial in breast cancer), CARA +6% (continued strength), NVAX +5.3% (Announces Extension of Contract for Advanced Development of Recombinant Influenza Products and Pandemic Preparedness With HHS-BARDA), QIWI+4.8% (may be attributed to Ukraine plans to limit FX cash withdrawals to UAH15K per day), PRKR +4.3% (. announces Qualcomm (QCOM) dismisses counterclaims against ParkerVision), GLUU +4% (may be attributed to MAT buying MEGA Brands), ZU +2.2% (continued momentum), ESI +2.1% ( S.A.C. Capital discloses 5.0% passive stake in 13G filing), ALU +1.9% (still checking for anything specific), ACT +1.7% (ticking higher; confirms that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Dronedarone Hydrochloride Tablets 400 mg), WDAY +1.2% (following positive MadMoney mention),WHR +0.7% (ticking higher following positive MadMoney mention), PEP +0.4% (Director Cook in letter to activist Nelson Peltz: Board and mgmt are comfortable and in complete alignment in rejecting your proposal), HOT +0.1% (following positive MadMoney mention).
Analyst comments: MITT +1.4% (upgraded to Buy at Wunderlich; tgt raised to $19), CS +1.1% (upgraded to Overweight from Equal Weight at Barclays), TOT +0.7% (upgraded to Buy from Neutral at UBS), TRIP +0.6% (upgraded to Neutral from Negative at Susquehanna)